Author: Karsyn Larsen

Influenza vaccination provided strong real-world protection for children in European primary care across two seasons, with overall vaccine effectiveness of 68% in 2022–2023 and 71% in 2023–2024. Protection was highest against influenza B and H1N1, while H3N2 showed lower and more variable effectiveness, supporting the need for higher uptake and continued monitoring.Read More

Read More

Influenza vaccination provided strong real-world protection for children in European primary care across two seasons, with overall vaccine effectiveness of 68% in 2022–2023 and 71% in 2023–2024. Protection was highest against influenza B and H1N1, while H3N2 showed lower and more variable effectiveness, supporting the need for higher uptake and continued monitoring.Read More

Read More

Amid ongoing geopolitical tensions and energy market volatility, Asian markets have shown resilience with mixed performances across key indices, reflecting a complex landscape of economic indicators and investor sentiment. In this environment, identifying high-growth tech stocks in Asia involves focusing on companies that demonstrate strong fundamentals, innovative capabilities, and the potential to adapt to both domestic opportunities and external challenges.Read More

Read More